Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?

Aberrant activity of tyrosine kinases has been proved to be associated with multiple diseases including fibrotic diseases. Tyrosine kinases inhibitors (TKIs) might be a novel approach to transform the anti-fibrotic treatment. However, both beneficial and adverse effects are observed by researchers w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Qu, Kai, Liu, Tian, Lin, Ting, Zhang, Xing, Cui, Ruixia, Liu, Sinan, Meng, Fandi, Zhang, Jingyao, Tai, Minghui, Wan, Yong, Liu, Chang
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341902/
https://ncbi.nlm.nih.gov/pubmed/27588502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11767
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados